Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 18 May 2023 for Larimar Therapeutics, Inc., €9,464. Read the official filing
Filing timeline
BuySaleJoseph Truitt
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joseph Truitt: trading record in brief
Our data holds just one disclosure by Joseph Truitt, dated 18 May 2023, reporting an open-market purchase worth €9,464 in Larimar Therapeutics, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joseph Truitt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
2,750 shares@ US$3.73100.0% of flowCommon StockSEC:0001062993-23-011545:0
Canonical exit: 15 Aug 2023 (T+90)
1 of 1 declaration
